When SAcfDNA was combined with IL-17A, the analyte previously reported as the sole biomarker prognostic power for distinguishing persistent bacteremia cases in this cohort [20], it did not improve the prognostic value of IL-17A by AUROC (Figure 4C) or in a logistic regression model (Supplementary Table 3). This evidence concerns the gene IL17A and bacterial infectious disease with sepsis.